Zinc sulfate in the prevention of total-body irradiation-induced early hematopoietic toxicity

A controlled study in a rat model
  • Mustafa Vecdi Ertekin
  • Ihsan Karslioĝlu
  • Fuat Erdem
  • Orhan Sezen
  • Akçahan Gepdiremen
  • Korkmaz Şerifoĝlu
Original Articles


Exposure to ionizing total-body radiation suppresses hematopoiesis, resulting in decreased production of blood cells. Many researchers have demonstrated the critical role of zinc (Zn) in diverse physiological processes, such as growth and development, maintenance and priming of the immune system, and tissue repair. The aim of the present study was to determine the effects of zinc sulfate (40 mg/kg and 80 mg/kg) on early hematopoietic toxicity, caused by total-body irradiation (TBI) of rats with a single dose of 8 Gy. Both in the Zn 40 and in the Zn 80 groups, there were significantly increased white blood cell (WBC) count, when compared with control group. The WBC count was higher in the control group than in the TBI group. This result was statistically significant (p<0.05). Both the TBI+Zn 40 and the TBI+Zn 80 groups had a significantly protected WBC count against TBI. No difference was detected in any final measurement of thrombocyte count and hemoglobin level with direct comparison among all groups, with the exception that the hemoglobin level in the Zn 80 group compared to the control group. Whereas hemoglobin level in the control group was at a median figure of 13.98 g/dL (13.30–14.80), it was at a median figure of 14.25 g/dL (14.10–15.50) in the Zn 80 group. It would be worth while studying the effect of oral zinc sulfate supplements in radiation-treated cancer patients, in the hope of reducing radiation-induced toxicity.

Index Entries

Total body irradiation WBC thrombocyte hemoglobin level zinc sulfate radioprotection 


  1. 1.
    M. V. Ertekin, H. Uslu, I. Karslioglu, et al., Effect of oral zinc sulphate supplementation on agents of oropharyngeal infection in patients receiving radiotherapy for head and neck cancer, J. Int. Med. Res. 31, 251–266 (2003).Google Scholar
  2. 2.
    D. Porock, Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework, Eur. J. Cancer Care 11, 33–43 (2002).CrossRefGoogle Scholar
  3. 3.
    K. E. Sabitha and C. S. Shyamaladevi, Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy, Oral Oncol. 35, 273–277 (1999).PubMedCrossRefGoogle Scholar
  4. 4.
    D. Kilic, H. Sayan, B. Gonul, et al., The effect of granulocyte macrophage-colony stimulating factor on glutathione and lipid peroxidation in a rat model, Eur. J. Surg. Oncol. 26, 701–704 (2000).PubMedCrossRefGoogle Scholar
  5. 5.
    N. Y. Haboubi, O. El-Zammer, S. T., O'Dwyer, et al., Radiation bowel disease: pathogenesis and management, Colorectal Dis. 2, 322–329 (2000).CrossRefGoogle Scholar
  6. 6.
    N. O. Mackova and P. Pedorocko, Effect of liposomal muramyl tripeptide phosphatidyl-ethanolamine and indomethacin on hematopoietic recovery in irradiated mice, Physiol. Res. 51, 511–521 (2002).PubMedGoogle Scholar
  7. 7.
    M. A. Mouthon, A. Van Der Meeren, M. H. Gaugler, et al., Thrombopoietin promotes hemetopoietic recovery and survival after high dose whole body irradiation, Int. J. Radiat. Oncol. Biol. Phys. 43, 867–875 (1999).PubMedCrossRefGoogle Scholar
  8. 8.
    R. Neal, R. H. Matthews, P. Lutz, et al., Antioxidant role ofn-acetyl cysteine isomers following high dose irradiation, Free Radical Biol. Med. 34, 689–695 (2003).CrossRefGoogle Scholar
  9. 9.
    S. H. Kim, S. E. Lee, H. Oh, et al., The radioprotective effects of Bu-Zhong-Yi-Qi-Tang: a prescription of traditional Chinese medicine, Am. J. Chin. Med. 30, 127–137 (2002).PubMedCrossRefGoogle Scholar
  10. 10.
    Vijayalaxmi, M. L. Meltz, R. J. Reiter, et al., Melatonin and protection from genetic damage in blood and bone marrow: whole-body irradiation studies in mice, J. Pineal Res. 27, 221–225 (1999).PubMedCrossRefGoogle Scholar
  11. 11.
    G. L. Floersheim, N. Chiodetti, and A. Bieri, Differential radioprotection of bone marrow and tumour cells by zinc aspartate, Br. J. Radiol. 61, 501–508 (1988).PubMedGoogle Scholar
  12. 12.
    F. Momm, C. Bechtold, V. Rudat, et al., Alteration of radiation-induced hematotoxicity by amifostine, Int. J. Radiat. Oncol. Biol. Phys. 51, 947–951 (2001).PubMedCrossRefGoogle Scholar
  13. 13.
    H. Y. Hsu, Y. H. Ho, and C. C. Lin, Protection of mouse bone marrow by Si-Wu-Tang against whole body irradiation, J. Ethanopharmacol. 52, 113–117 (1996).CrossRefGoogle Scholar
  14. 14.
    W. Nothdurft, L. Kreja, and C. Selig, Acceleration of hemopoietic recovery in dogs after extended-field partial-body irradiation by treatment with colony-stimulating factors: rhG-CSF and rhGM-CSF, Int. J. Radiat. Oncol. Biol. Phys. 37, 1145–1154 (1997).PubMedCrossRefGoogle Scholar
  15. 15.
    A. Q. Truong-Tran, J. Carter, R. Ruffin, R., et al., New insights into the role of zinc in the respiratory epithelium, Immunol. Cell. Biol. 79, 170–177 (2001).PubMedCrossRefGoogle Scholar
  16. 16.
    E. Mocchegiani, M. Muzzioli, and R. Giacconi, Zinc metallothioneins, immune responses, survival and ageing, Biogerontology 1, 133–143 (2000).PubMedCrossRefGoogle Scholar
  17. 17.
    A. S. Prasad and O. Kucuk, Zinc in cancer prevention, Cancer Metast. Rev. 21, 291–295 (2002).CrossRefGoogle Scholar
  18. 18.
    B. N. Ames, Micronutrients prevent cancer and delay aging, Toxicol. Lett. 102(3), 5–18 (1998).PubMedCrossRefGoogle Scholar
  19. 19.
    E. Mocchegiani, R. Giacconi, M. Muzzioli, et al., Zinc, infections and immunose-nescense, Mech. Ageing Dev. 12, 21–35 (2000).Google Scholar
  20. 20.
    D. Bagchi, M. Bagchi, and S. J. Stohs, Comparative in vitro oxygen radical scavenging ability of zinc methionine and selected zinc salts and antioxidants, Gen. Pharmacol. 28, 85–91 (1997).PubMedGoogle Scholar
  21. 21.
    T. M. Bray and W. J. Bettger, The physiological role of zinc as an antioxidant, Free Radical Biol. Med. 8, 281–291 (1990).CrossRefGoogle Scholar
  22. 22.
    E. F. Rostan, H. V. DeBuys, D. L. Madey, et al., Evidence supporting zinc as an important antioxidant for skin, Int. J. Dermatol. 41, 606–611 (2002).PubMedCrossRefGoogle Scholar
  23. 23.
    M. Ebadi, M. P. Leuschen, H. el Refaey, et al., The antioxidant properties of zinc and metallothionein, Neurochem. Int. 29, 159–166 (1996).PubMedCrossRefGoogle Scholar
  24. 24.
    M. P. Zago and P. I. Oteiza, The antioxidant properties of zinc: interactions with iron and antioxidants, Free Radical Biol. Med. 31, 266–274 (2001).CrossRefGoogle Scholar
  25. 25.
    M. Guven, B. Ozturk, A. Sayal, et al., Lipid peroxidation and antioxidant system in the blood of patients with Hodgkin's disease, Clin. Biochem. 33, 209–212 (2002).CrossRefGoogle Scholar
  26. 26.
    E. Jourdan, N. Emonet-Piccardi, C. Didier, et al., Effects of cadmium and zinc on solar-simulated light-irradiated cells: potential role of zinc-metallothionein in zinc-induced genoprotection, Arch. Biochem. Biophys. 405, 170–177 (2002).PubMedCrossRefGoogle Scholar
  27. 27.
    R. S. MacDonald, The role of zinc in growth a cell proliferation, J. Nutr. 130(5S, Suppl), 1500–1508 (2000).Google Scholar
  28. 28.
    S. R. Gogu and K. C. Agrawal, The protective effect of zinc and N-Acetylcysteine in modulating Zidovudine induced hematopoietic toxicity, Life Sci. 59, 1323–1329 (1996).PubMedCrossRefGoogle Scholar
  29. 29.
    L. Rink and P. Gabriel, Extracellular and immunological actions of zinc, Biometals 14, 367–383 (2001).PubMedCrossRefGoogle Scholar
  30. 30.
    A. S. Prasad, Zinc and immunity, Mol. Cell. Biochem. 188, 63–69 (1998).PubMedCrossRefGoogle Scholar
  31. 31.
    R. E. Black and S. Sazawal, Zinc and chilhood infections disease morbidity and mortality, Br. J. Nutr. 85(Suppl. 2), 125–129 (2001).CrossRefGoogle Scholar
  32. 32.
    E. Mocchegiani, S. Veccia, F. Ancarani, et al., Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS, Int. J. Immunopharmacol. 17, 719–727 (1995).PubMedCrossRefGoogle Scholar
  33. 33.
    F. T. Al-Gurairi, M. Al-Waiz, and K. E. Sharquie, Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial, Br. J. Dermatol. 146, 423–431 (2002).PubMedCrossRefGoogle Scholar
  34. 34.
    K. E. Sharquie, R. A. Najim, I. B. Farjou, et al., Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis, Clin. Exp. Dermatol. 26, 21–26 (2001).PubMedCrossRefGoogle Scholar
  35. 35.
    A. H. Baqui, R. E. Black, S. El Arifeen, et al., Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial, Br. Med. J. 325, 1059–1066 (2002).CrossRefGoogle Scholar
  36. 36.
    Z. A. Bhutta, S. M. Bird, R. E. Black, et al., Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials, Am. J. Clin. Nutr. 72, 1516–1522 (2000).PubMedGoogle Scholar
  37. 37.
    C. Ripamonti, E. Zecca, C. Brunelli, et al., A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation, Cancer 82, 1938–1945 (1998).PubMedCrossRefGoogle Scholar
  38. 38.
    A. Federico, P. Iodice, P. Federico, et al., Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract, Eur. J. Clin. Nutr. 55, 293–297 (2001).PubMedCrossRefGoogle Scholar
  39. 39.
    F. Girodon, P. Galan, A. L. Monget, et al., Impact of trace elements and vitamin supplementation on immunity and infections in institutionalised elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network, Arch. Intern. Med. 159, 748–754 (1999).PubMedCrossRefGoogle Scholar
  40. 40.
    A. H. Shankar and A. S. Prasad, Zinc and immune function: the biological basis of altered resistance to infection, Am. J. Clin. Nutr. 68(Suppl.), 447–463 (1998).Google Scholar
  41. 41.
    N. Donmez, H. H. Donmez, E. Keskin, et al., Effects of zinc supplementation to ration on some hematological parameters in broiler chicks, Biol. Trace Element Res. 87, 125–131 (2002).CrossRefGoogle Scholar
  42. 42.
    B. H. Bay, G. Singh, and K. H. Sit, Effect of intraperitoneal zinc on the hematological profiles of C57/6J mice, Singapore Med. J. 36, 271–272 (1995).PubMedGoogle Scholar
  43. 43.
    H. Ding, R. Peng, R. Kong, et al., Effects of high dietary zinc on mice (II)—Influence on growth, blood composition and immune function, Wei Sheng Yan Jiu 26, 325–326 (1997).PubMedGoogle Scholar
  44. 44.
    V. Rupic, L. Ivandija, S. Luterotti, et al., Plasma proteins and hematological parameters in fattening pigs fed different sources of dietary zinc, Acta Vet. Hung. 46, 111–126 (1998).PubMedGoogle Scholar
  45. 45.
    R. P. Gupta, P. C. Verma, and R. K. Gupta, Experimental zinc deficiency in guinea-pigs: clinical signs and some haematological studies, Br. J. Nutr. 54, 421–428 (1985).PubMedCrossRefGoogle Scholar
  46. 46.
    J. Matsubara, T. Shida, K. Ishioka, et al., Protective effect of zinc against lethality in irradiated mice, Environ. Res. 41, 558–567 (1986).PubMedCrossRefGoogle Scholar
  47. 47.
    L. Cai and M. G. Cherian, A daptive response to ionizing radiation-induced chromosome aberrations in rabbit lymphocytes: effect of pre-exposure to zinc, and copper salts, Mutat. Res. 369, 233–241 (1996).PubMedCrossRefGoogle Scholar
  48. 48.
    G. L. Floersheim and P. Floersheim, Protection against ionising radiation and synergism with thiols by zinc aspartate, Br. J. Radiol. 59, 597–602 (1986).PubMedGoogle Scholar
  49. 49.
    M. T. Leccia, M. J. Richard, J. C. Beani, et al., Protective effect of selenium and zinc on UV-A damage in human skin fibroblasts, Photochem. Photobiol. 58, 548–553 (1993).PubMedGoogle Scholar
  50. 50.
    F. W. Sunderman, Jr., The influence of zinc on apoptosis, Ann. Clin. Lab. Sci. 25, 134–142 (1995).PubMedGoogle Scholar
  51. 51.
    G. L. Floersheim and A. Bieri, Further studies on selective radioprotection by organic zinc salts and synergism of zinc aspartate with WR 2721, Br. J. Radiol. 63, 468–475 (1990).PubMedCrossRefGoogle Scholar
  52. 52.
    C. K. Bomfort, S. B. Sherriff, I. H. Kunkler, et al., Textbook of Radiotherapy, 5th ed. Longman, London (1993).Google Scholar
  53. 53.
    R. M. Nagler, Y. Eichen and A. Nagler, Redox metal chelation ameliorates radiation-induced bone marrow toxicity in a mouse model, Radiat. Res. 156, 205–209 (2001).PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2004

Authors and Affiliations

  • Mustafa Vecdi Ertekin
    • 1
  • Ihsan Karslioĝlu
    • 1
  • Fuat Erdem
    • 2
  • Orhan Sezen
    • 1
  • Akçahan Gepdiremen
    • 3
  • Korkmaz Şerifoĝlu
    • 1
  1. 1.Department of Radiation OncologyAtatürk University Faculty of MedicineErzurumTurkey
  2. 2.Department of HematologyAtatürk University Faculty of MedicineErzurumTurkey
  3. 3.Department of PharmacologyAtatürk University Faculty of MedicineErzurumTurkey

Personalised recommendations